DuPont C8 Settlement: $670.7M, $1.185B, and State Payouts

The DuPont C8 settlement is not one deal but a chain of them, resolving claims that DuPont contaminated drinking water with perfluorooctanoic acid (PFOA), the chemical the company internally called C8. The largest pieces are a 2005 West Virginia class action worth up to $405 million that funded a landmark health study, a 2017 global settlement of $670.7 million resolving about 3,500 personal injury lawsuits tied to six diseases, and a 2023 settlement of $1.185 billion with public water systems across the country. State settlements with Ohio ($110 million) and New Jersey (up to $875 million) have since added to the total, and a medical monitoring program remains open to eligible residents.

What C8 Is and How It Got Into the Water

DuPont opened its Washington Works plant near Parkersburg, West Virginia, in 1948 and began using PFOA to manufacture Teflon in 1951.¹ Over the following decades, the chemical entered the environment through air emissions, unlined waste pits that leached into groundwater, and runoff into creeks feeding the Ohio River.² By 1984, DuPont’s own monitoring confirmed C8 in the public water supplies of Lubeck, West Virginia, and Little Hocking, Ohio.³

Internal records later showed employees had flagged possible toxicity as early as 1954, that a 1981 study of 50 female workers found a statistically significant increase in birth defects among the exposed, and that 1982 memos noted C8 accumulates in the human body.³ The company continued discharging the chemical and did not disclose the findings to regulators for years.

The 2005 Class Action Settlement

The core class action, Jack W. Leach, et al. v. E.I. du Pont de Nemours & Co. (No. 01-C-608), was filed in August 2001 in the Circuit Court of Wood County, West Virginia. It represented roughly 80,000 people in six water districts across West Virginia and Ohio whose drinking water had been contaminated by C8 from Washington Works.⁴

A West Virginia court approved the settlement in early 2005. Its initial payment component was $107.6 million,⁵ but DuPont’s total commitment reached $405 million, including $335 million for the settlement itself and $70 million for a health and education project.⁴ The agreement had four moving parts:

Water treatment: DuPont installed filtration in the contaminated districts, spending more than $20 million on the equipment.⁶
An independent science panel of three epidemiologists, funded with more than $30 million, to determine whether C8 exposure was linked to human disease.⁶
Up to $235 million for medical monitoring and screening if the panel found a probable link to any disease.⁵
Preserved personal injury rights: class members could not sue for personal injury until the panel finished, but DuPont was not shielded from suits once a probable link was found.⁴

One provision proved decisive. DuPont agreed to accept “general causation” for any disease the panel linked to C8, meaning the company could not later argue in personal injury lawsuits that the science tying C8 to those diseases was insufficient.⁷

The Six Diseases Linked to C8

The C8 Science Panel — epidemiologists Tony Fletcher, David Savitz, and Kyle Steenland — was chosen jointly by the plaintiffs and DuPont.⁸ Its companion C8 Health Project enrolled roughly 69,000 participants from the affected water districts between 2005 and 2006 and collected blood samples, health surveys, and medical records.⁹

Between 2011 and 2012, the panel concluded a “probable link” existed between PFOA exposure and six conditions:⁸

Kidney cancer
Testicular cancer
Thyroid disease
Ulcerative colitis
Diagnosed high cholesterol
Pregnancy-induced hypertension, including preeclampsia

Those six diseases became the eligibility gate for the personal injury lawsuits that followed. The panel completed its work in 2013 and no longer exists.⁸

Medical Monitoring for Eligible Class Members

The medical monitoring program established under the 2005 settlement remains active. It offers free screening for the six linked conditions to eligible class members, though participation has been low relative to the roughly 80,000 people who qualify.¹⁰ If you lived in one of the six affected water districts during the relevant exposure period, you may still be eligible.

The 2017 Personal Injury Settlement: $670.7 Million

With the science panel’s findings in hand, roughly 3,500 personal injury lawsuits were filed and consolidated into a multidistrict litigation in the U.S. District Court for the Southern District of Ohio. The court picked bellwether cases to test the claims.

Three Bellwether Verdicts

All three went for the plaintiffs, and the punitive damages climbed sharply from case to case:

Carla Bartlett (October 2015), kidney cancer: $1.6 million total, with $1.1 million for negligence and $500,000 for emotional distress.¹¹
David Freeman (July 2016), testicular cancer: $5.1 million compensatory and $500,000 punitive, totaling $5.6 million, with the jury finding DuPont’s conduct malicious.¹¹
Kenneth Vigneron (December 2016 to January 2017), testicular cancer: $2 million compensatory and $10.5 million punitive, totaling $12.5 million.¹¹

The Global Settlement

In February 2017, after three straight losses at trial, DuPont and its corporate successor Chemours agreed to a $670.7 million settlement, split evenly at $335.35 million each.¹² It covered the roughly 3,500 pending personal injury cases, all of which involved one of the six diseases the science panel had linked to C8.¹³ Neither company admitted liability.

The Abbott Verdict

Cases filed after the global deal continued to reach juries. In January 2020, Travis Abbott was awarded $40 million and his wife Julie $10 million for injuries related to his testicular cancer.¹⁴ The district court reduced Julie Abbott’s award to $250,000 under the Ohio Tort Reform Act.¹⁵ The Sixth Circuit affirmed the judgment on December 5, 2022, upholding collateral estoppel on duty, breach, and causation from the earlier bellwethers.¹⁶

The 2023 Water Utility Settlement: $1.185 Billion

On June 2, 2023, DuPont, Chemours, and Corteva announced a $1.185 billion settlement to resolve PFAS drinking water claims brought by public water systems nationwide.¹⁷ The deal is part of MDL 2873 (In re: Aqueous Film-Forming Foams Products Liability Litigation), centralized in the U.S. District Court for the District of South Carolina before Judge Richard M. Gergel.¹⁸

Chemours paid $592 million, DuPont paid $400 million, and Corteva paid $193 million.¹⁷ The settlement covers public water systems that have detected PFAS or are required to test for it under federal or state law. Personal injury claims and state attorney general natural-resource-damage actions are excluded. Judge Gergel granted final approval after a fairness hearing on December 14, 2023, and the settlement became effective on April 17, 2024.¹⁸

Recovery for individual water systems is calculated by formula based on water flow rates and PFAS detection levels. Phase 2 deadlines for systems that detected PFAS more recently extend into 2026, with a testing claims deadline of March 31, 2026, and an action fund deadline of July 31, 2026.¹⁹ Water systems can also participate in the separate, much larger 3M PFAS settlement in the same MDL, which ranges from $10.5 billion to $12.5 billion over 13 years depending on participation.²⁰

State Settlements: Ohio and New Jersey

Ohio: $110 Million

On November 29, 2023, Governor Mike DeWine and Attorney General Dave Yost announced a $110 million settlement with DuPont, Chemours, and Corteva over contamination from Washington Works. The money goes into an environmental restoration fund: 80% for pollution from the plant, 16% for firefighting foam damages, and 4% for natural resource mitigation.²¹ Ohio alleged the facility released PFOA into the air and the Ohio River from the 1950s through 2013, and Yost said the payment would be a lump sum issued within 10 days.²²

New Jersey: Up to $875 Million

On August 4, 2025, the three companies reached a proposed settlement with the New Jersey Department of Environmental Protection valued at up to $875 million over 25 years, with a pre-tax present value of about $500 million.²³ It resolves claims at four current and former manufacturing sites — Chambers Works, Parlin, Pompton Lakes, and Repauno — and includes $225 million for natural resource damages, $525 million for environmental cleanup, and approximately $125 million in costs, penalties, and punitive damages.²⁴ Costs are split among Chemours (50%), DuPont (35.5%), and Corteva (14.5%).

The companies must also continue cleanup at all four sites, transfer 73 acres near Ramapo State Forest to the state, and place conservation easements on nearly 1,400 additional acres. A reserve fund of up to $475 million, backed by surety bonds, secures the remediation obligations. The agreement was published for public comment in September 2025 and needs final court approval, with the earliest entry date set for January 1, 2026.²⁴

Who Actually Pays: DuPont, Chemours, and Corteva

The settlements name three companies because DuPont’s fluorochemicals business was spun off as The Chemours Company in 2015, and DuPont later split again during a 2017 merger with Dow and the 2019 reorganization of DowDuPont, producing Corteva.²⁵ Under a binding Memorandum of Understanding signed on January 22, 2021, the three agreed to share legacy PFAS costs on a 50-50 basis, with Chemours covering half and DuPont and Corteva together covering the other half. The arrangement is capped at $4 billion in qualified spending and runs through the end of 2040. Between DuPont and Corteva, costs up to $300 million are split equally; beyond that, DuPont bears 71% and Corteva bears 29%.²⁶ That is why announcements about “DuPont” settlements now typically list all three payers.

The Broader PFAS Litigation Still Underway

The C8 cases opened the door to a wave of PFAS lawsuits that reaches well beyond Parkersburg. MDL 2873 in South Carolina has grown to more than 10,000 associated cases involving tens of thousands of plaintiffs, covering personal injury, property damage, and medical monitoring claims tied to PFAS in firefighting foams and other products.²⁷ In 2024, the EPA finalized maximum contaminant levels for six PFAS compounds in drinking water. Litigation over those standards continues, and in January 2026 a federal appeals court rejected a request from the Trump administration to vacate the rules for four of the compounds.¹⁹

For residents of the original six water districts, the practical takeaway is that the 2017 personal injury settlement closed the door on the pending cases at that time, but the medical monitoring program from the 2005 class action continues to offer free screening for the six linked diseases. For public water systems, the 2023 settlement’s Phase 2 claim windows are still open through mid-2026. And for anyone tracking the money: the 2023 utility settlement alone is larger than every prior DuPont C8 settlement combined, and the New Jersey deal, if approved, will add substantially more.

1
PFAS Project. Parkersburg West Virginia
2
EPA. Chemours Washington Works History and Safe Drinking Water Act Settlements
3
HuffPost Highline. Welcome to Beautiful Parkersburg
4
Business & Human Rights Resource Centre. DuPont Case
5
Chemical & Engineering News. DuPont Settles PFOA Case
6
Hill, Peterson, Carper, Bee & Deitzler. C8 Class Action Settlement
7
U.S. District Court, Southern District of Ohio. MDL Document 4777
8
C8 Science Panel. C8 Science Panel
9
National Institutes of Health. C8 Health Project
10
C-8 Medical Monitoring Program. C-8 Medical Monitoring Program
11
Hill, Peterson, Carper, Bee & Deitzler. DuPont C8
12
Chemours. The Chemours Company Settles Indemnification Claims
13
News and Sentinel. DuPont Reaches C8 Settlement Agreement for $670M
14
FindLaw. Abbott v. DuPont, Sixth Circuit
15
U.S. Government Publishing Office. Abbott v. DuPont District Court Opinion
16
U.S. Supreme Court. Abbott v. DuPont Petition Appendix
17
Corteva. Chemours DuPont and Corteva Reach Comprehensive PFAS Settlement With US Water Systems
18
PFAS Water Settlement. DuPont Frequently Asked Questions
19
National League of Cities. PFAS Settlement Deadlines Updated
20
State of Maine Attorney General. 3M and DuPont Settlement Info Sheet
21
Governor of Ohio. State Secures $110 Million Settlement With DuPont for Environmental Restoration Along Ohio River
22
Ohio Capital Journal. DuPont Chemours and Corteva Will Pay Ohio $110 Million in Settlement Over Forever Chemicals
23
DuPont. Chemours DuPont and Corteva Reach Agreement With the State of New Jersey
24
New Jersey DEP. DuPont
25
Chemours. Chemours Amended Complaint
26
U.S. SEC. MOU Between DuPont, Corteva, and Chemours
27
U.S. District Court, District of South Carolina. MDL 2873